138 related articles for article (PubMed ID: 37263180)
21. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
Crucitti P; Gallo IF; Santoro G; Mangiameli G
Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
[TBL] [Abstract][Full Text] [Related]
22. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
[TBL] [Abstract][Full Text] [Related]
23. Lung cancer screening with low-dose computed tomography at a tertiary hospital in Anhui, China and secondary analysis of trial data.
Shan W; Chen Z; Wei D; Li M; Qian L
Br J Radiol; 2021 Feb; 94(1118):20200438. PubMed ID: 33353400
[TBL] [Abstract][Full Text] [Related]
24. The Introduction of Low-Dose CT Imaging and Lung Cancer Overdiagnosis in Chinese Women.
Wang M; Lin S; He N; Yang C; Zhang R; Liu X; Suo C; Lin T; Chen H; Xu W
Chest; 2023 Jan; 163(1):239-250. PubMed ID: 35998705
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China.
Guo LW; Chen Q; Shen YC; Meng QC; Zheng LY; Wu Y; Cao XQ; Xu HF; Liu SZ; Sun XB; Qiao YL; Zhang SK
JAMA Netw Open; 2020 Nov; 3(11):e2019039. PubMed ID: 33141158
[TBL] [Abstract][Full Text] [Related]
26. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
[TBL] [Abstract][Full Text] [Related]
27. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the efficacy of lung cancer screening in urban areas of Henan Province by low-dose computed tomography from 2013 to 2017].
Guo LW; Liu SZ; Zhang SK; Yang FN; Wu Y; Zheng LY; Chen Q; Cao XQ; Sun XB
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):155-159. PubMed ID: 32135652
[No Abstract] [Full Text] [Related]
29. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Thomas A; Pattanayak P; Szabo E; Pinsky P
Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
[TBL] [Abstract][Full Text] [Related]
30. Establishing a Cohort and a Biorepository to Identify Biomarkers for Early Detection of Lung Cancer: The Nashville Lung Cancer Screening Trial Cohort.
Lakhani DA; Chen SC; Antic S; Muterspaugh A; Cook C; Liu N; Shujat H; Jouan S; Winston B; Fields K; Wenstrup J; Block SL; Hinton A; Miller A; Atmajoana S; Helton JT; Patel K; Balar AB; Brewer K; Nag S; Singh R; Disher A; Huerta L; Fremont R; Rickman O; Chen H; Eisenberg R; Sandler KL; Paulson A; Walker RC; Shah C; Smith GT; Landman B; Deppen S; Grogan EL; Aldrich MC; Massion PP
Ann Am Thorac Soc; 2021 Jul; 18(7):1227-1234. PubMed ID: 33400907
[No Abstract] [Full Text] [Related]
31. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.
Sverzellati N; Silva M; Calareso G; Galeone C; Marchianò A; Sestini S; Sozzi G; Pastorino U
Eur Radiol; 2016 Nov; 26(11):3821-3829. PubMed ID: 26868497
[TBL] [Abstract][Full Text] [Related]
32. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
Murugan VA; Kalra MK; Rehani M; Digumarthy SR
J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
[TBL] [Abstract][Full Text] [Related]
33. Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.
Lam S; Bai C; Baldwin DR; Chen Y; Connolly C; de Koning H; Heuvelmans MA; Hu P; Kazerooni EA; Lancaster HL; Langs G; McWilliams A; Osarogiagbon RU; Oudkerk M; Peters M; Robbins HA; Sahar L; Smith RA; Triphuridet N; Field J
J Thorac Oncol; 2024 Jan; 19(1):36-51. PubMed ID: 37487906
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
[TBL] [Abstract][Full Text] [Related]
35. Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans.
Ritchie AJ; Sanghera C; Jacobs C; Zhang W; Mayo J; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Manos D; Seely JM; Burrowes P; Bhatia R; Atkar-Khattra S; van Ginneken B; Tammemagi M; Tsao MS; Lam S;
J Thorac Oncol; 2016 May; 11(5):709-717. PubMed ID: 26994641
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
37. Special issue "The advance of solid tumor research in China": Participants with a family history of cancer have a higher participation rate in low-dose computed tomography for lung cancer screening.
Guo LW; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Liu SZ; Sun XB; Zhang SK
Int J Cancer; 2023 Jan; 152(1):7-14. PubMed ID: 35362560
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer screening using multi-slice thin-section computed tomography and autofluorescence bronchoscopy.
McWilliams AM; Mayo JR; Ahn MI; MacDonald SL; Lam SC
J Thorac Oncol; 2006 Jan; 1(1):61-8. PubMed ID: 17409828
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
